Physician
Neurology
Dr. Ninan T. Mathew, MD
|
|
Give Review
Ninan Mathew practices Neurology. He studied medicine at Baylor College of Medicine. Ninan Mathew is a published doctor. He published 98 publications, including: 'Cardiovascular safety of 5HT1B/1D agonists--is there a cause for concern?'
Publications
- Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease.
- Efficacy and Safety of MAP0004, Orally Inhaled DHE in Treating Migraines With and Without Allodynia.
- Pathophysiology of chronic Migraine and mode of action of preventive medications.
- A practice guide for continuous opioid therapy for refractory daily Headache: patient selection, physician requirements, and treatment monitoring.
- A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic Migraine: a pilot study.
- Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
- Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute Migraine intervention.
- Dynamic optimization of chronic Migraine treatment: current and future options.
- Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial.
- Rational combination therapy in refractory Migraine.
- The use of questions to determine the presence of photophobia and phonophobia during Migraine.
- Botulinum toxin type A for the treatment of nummular Headache: four case studies.
- Predictors of response to botulinum toxin type A (BoNTA) in chronic daily Headache.
- The impact of topiramate on health-related quality of life indicators in chronic Migraine.
- The prophylactic treatment of chronic daily Headache.
- Are triptans effective and safe when taken during the aura phase of Migraine?
- Evaluating the triptans.
- Clinical recognition of allodynia in Migraine.
- Early treatment of Migraine with rizatriptan: a placebo-controlled study.
- Early intervention with almotriptan improves sustained pain-free response in acute Migraine.
- Tolerability and safety of eletriptan in the treatment of Migraine: a comprehensive review.
- Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mg.
- The Use of Botulinum Toxin Type A in Headache Treatment.
- Prophylaxis of migraine, transformed migraine, and Cluster headache with topiramate.
- Intractable Cluster headaches in a migraineur.
- Intranasal civamide for the treatment of episodic Cluster headaches.
- Use of rescue medication in trials of almotriptan versus placebo in the treatment of acute Migraine.
- Almotriptan increases pain-free status in patients with acute Migraine treated in placebo-controlled clinical trials.
- Orally administered betahistine and regional cerebral blood flow in cerebrovascular disease.
- Treatment with glycerol of cerebral oedema due to acute cerebral infarction.
- Still more on ergotamine withdrawal.
- Cerebral embolization: prospective clinical analysis of 42 cases.
- Internal carotid artery occlusion in cavernous sinus thrombosis.
- Familial ocular myopathy with curare sensitivity.
- Abnormal CT-Scans in Migraine.
- Biochemical comparison of Migraine and stroke.
- Abnormal cerebroSpinal fluid-blood flow dynamics. Implications in diagnosis, treatment, and prognosis in normal pressure hydrocephalus.
- Pseudohypertrophic myopathy in cysticercosis.
- Increased cerebral blood volume in benign intracranial hypertension.
- Atrial fibrillation associated with seizure in a case of frontal meningioma.
- Cerebral angiographic features in tuberculous meningitis.
- Painful ophthalmoplegia.
- Valproate and lamotrigine in Migraine.
- Hyperlipidemic neuropathy and dementia.
- Effect of regional cerebral blood flow of compression by a mass lesion.
- Naratriptan: a review.
- Vertebrobasilar arterial insufficiency with dementia. Controlled trials of treatment with betahistine hydrochloride.
- Clinical and hemodynamic effects during treatment of vascular Headaches with verapamil.
- Tachyphylaxis in Migraine prophylaxis.
- Headache after frequent triptan use.
- Is Cluster headache due to indolent inflammation in the cavernous sinus?
- Valproate in the prophylaxis of Migraine.
- Clinical subtypes of Cluster headache and response to lithium therapy.
- Regional cerebral blood flow in the diagnosis of vascular Headache.
- Double-blind evaluation of glycerol therapy in acute cerebral infarction.
- Valproate in intractable Headache.
- Lithium carbonate has no measurable effect on cerebral hemodynamics in Cluster headaches.
- Redistribution of regional cerebral blood flow after glycerol infusion in acute cerebral infarction.
- Amelioration of ergotamine withdrawal symptoms with naproxen.
- Abortive versus prophylactic treatment of Migraine--a reappraisal.
- Advances in Cluster headache.
- Cardiovascular safety of 5HT1B/1D agonists--is there a cause for concern?
- Indomethacin responsive Headache syndromes.
- Drug-induced Headache.
- Medication misuse Headache.
- Severe diffuse intracranial vasospasm as a cause of extensive migrainous cerebral infarction.
- Concomitant administration of antiemetics is not necessary with intramuscular dihydroergotamine.
- Migraine and hypertension.
- Review of clinical trials using early acute intervention with oral triptans for Migraine management.
- What are Cluster headaches and how are they treated?
- Long-term subcutaneous sumatriptan in Cluster headache.
- Transformed migraine, analgesic rebound, and other chronic daily Headaches.
- Transformed or evolutive Migraine.
- Assessment of chronic refractory Headache: the role of the MMPI-2.
- Prophylaxis of migraine and mixed Headache. A randomized controlled study.
- A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine Headache.
- Serotonin 1D (5-HT1D) agonists and other agents in acute Migraine.
- Pathophysiology, epidemiology, and impact of Migraine.
- Transformation of episodic migraine into daily Headache: analysis of factors.
- Percutaneous radiofrequency trigeminal gangliorhizolysis in intractable Cluster headache.
- The International Headache Society (IHS) Headache classification as applied to a Headache clinic population.
- Tolerability of sumatriptan: clinical trials and post-marketing experience.
- Utility of topiramate for the treatment of patients with chronic Migraine in the presence or absence of acute medication overuse.
- Dosing and administration of ergotamine tartrate and dihydroergotamine.
- Zolmitriptan. Introduction.
- Antiepileptic drugs in Migraine prevention.
- Coexistence of Migraine and idiopathic intracranial hypertension without papilledema.
- Defining optimal dosing for sumatriptan tablets in the acute treatment of Migraine.
- Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of Migraine.
- Differential diagnosis in Headache--identifying migraine in primary care.
- Drug induced refractory Headache--clinical features and management.
- Extratrigeminal Cluster headache.
- Chronic refractory Headache.
- Office-based treatment of acute Migraine with dihydroergotamine mesylate.
- Classification of daily and near-daily Headaches: proposed revisions to the IHS criteria.
- Transformed Migraine.
- Valproate in the treatment of persistent chronic daily Headache. An open label study.
Procedures Preformed
- Non-Cosmetic Chemodenervation
Conditions Treated
- Ataxia
- Autonomic Disorders
- Cluster Headache
- Dystonia
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Education
-
Baylor College of Medicine -
University of Kerala Medical College
Hospital
-
Park Plaza Hospital
Drug Facts
| NPI NUMBER | 1457379562 | |
| NPPES Provider LastName | MATHEW | |
| NPPES Provider FirstName | NINAN | |
| NPPES Provider ZIPCode | 770241018 | |
| NPPES Provider State | TX | |
| Specialty Description | Neurology | |
| Total Claim Count | 1373.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1457379562 |
| Last Name Of The Provider | MATHEW |
| First Name Of The Provider | NINAN |
| View All |
Similar Doctors
|
|
Dr. Navdeep S. Sangha, MD |
|
|
Dr. Stanley H. Appel, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Ian L. Goldsmith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward F. Good, MD |
|
|
Dr. Amy L. Naquin-Chappel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Madhureeta Achari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeanette C. Hartshorn, PHD |
|
Dr. Payman Sadeghi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Minh-Ngoc M. Dang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Milan Dimitrijevic, MD |
|
|
Dr. Proleta Datta, MD |
|
|
Dr. Syed O. Kazmi, MD |
|
|
Dr. Adeola Olowu, MD |
|
|
Dr. Fabio Fernandez, MD
This Doctor is OpenDoctor Recommended.
|